EpiEP Inc. They have developed an innovative epicardial access system called EpiAccess™, which has received FDA clearance and is CE marked. This system features a unique pressure-guided needle that provides real-time guidance to physicians during epicardial access procedures, ensuring safe and precise needle tip location.

Unlike traditional approaches that involve working on the inside of the heart, EpiEP's epicardial approach allows physicians to operate on the outer surface of the heart muscle. This technique has shown great promise in treating conditions such as ventricular tachycardia, atrial fibrillation, and left atrial appendage ligation. Physicians who have used the EpiAccess™ System during clinical trials have praised its performance and the ability to display adjunctive data that confirms access into the pericardial cavity.

This technology platform can be calibrated for other anatomical locations as well. EpiEP Inc